wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q48722303-EDCA3055-2050-48E1-81D1-4C35E29D5E2C
Q48722303-EDCA3055-2050-48E1-81D1-4C35E29D5E2C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48722303-EDCA3055-2050-48E1-81D1-4C35E29D5E2C
Patterns of sorafenib and TACE treatment of unresectable hepatocellular carcinoma in a Chinese population: subgroup analysis of the GIDEON study.
P2860
Q48722303-EDCA3055-2050-48E1-81D1-4C35E29D5E2C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48722303-EDCA3055-2050-48E1-81D1-4C35E29D5E2C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3722b04f183238f4bf1021b7b7c075e486801040
P2860
Sorafenib combined with transarterial chemoembolization versus transarterial chemoembolization alone for advanced-stage hepatocellular carcinoma: a propensity score matching study.